Drugs and therapeutics
Open access articles in drugs and therapeutics. Articles from Drug Target Insights, Clinical Medicine: Therapeutics, Perspectives in Medicinal Chemistry.
Latest news
- Author interview with Dr Thomas Ostermann
-
- 24/Mar/2010
- Author interview with Dr Ross Grant
-
- 11/Mar/2010
- Follow our open access journals on Twitter
-
- 11/Mar/2010
- Published in February
-
- 11/Mar/2010
- New article notifications in your in-box
-
- 22/Feb/2010
- Indian Journal of Clinical Medicine introductory editorial available
-
- 11/Feb/2010
- Published in January
-
- 11/Mar/2010
- Seven more journals added to CAS
-
- 26/Jan/2010
- Directory of Open Access Journals interview
-
- 28/Jan/2010
- Author interview with Dr Hiro Koshiyama
-
- 28/Jan/2010
- Author interview with Dr Nicolas Carels
-
- 22/Jan/2010
- Interview with Clinical Medicine Insights: Cardiology editorial board meber Dr Arnon Blum
-
- 12/Jan/2010
- Five more journals accepted by DOAJ
-
- 05/Jan/2010
- Open access articles published in December
-
- 04/Jan/2010
- Open access articles published in November
-
- 09/Dec/2009
- 2010 special issues
-
- 07/Dec/2009
- Proposals invited for Translational Oncogenomics special issue
-
- 07/Dec/2009
- Proposals invited for Signal Transduction Insights special issue
-
- 07/Dec/2009
- Proposals invited for Rehabilitation Process and Outcome special issue
-
- 07/Dec/2009
- Proposals invited for Primary Prevention Insights special issue
-
- 07/Dec/2009
- Proposals invited for Perspectives in Medicinal Chemistry special issue
-
- 07/Dec/2009
- Proposals invited for Palliative Care: Research and Treatment special issue
-
- 07/Dec/2009
- Proposals invited for Immunotherapy Insights special issue
-
- 07/Dec/2009
- Proposals invited for Human Parasitic Diseases special issue
-
- 07/Dec/2009
Latest articles
- Evaluation of Knowledge, Attitude and Performance of the Mothers of Children Affected by Cutaneous Leishmaniasis
- Network Robustness Due to Multiple Positive Feedback Loops: A Systematic Study of a Th Cell Differentiation Model
- Reconceptualizing Autism: Moving Beyond the Behavioral to Address Cause, Cure and Prevention
- Coffee-Induced Hypokalaemia
- Pharmacotherapy of Major Depressive Disorder: Focus on Desvenlafaxine Succinate
- Hemorrhagic Cystitis in a Patient Receiving Docetaxel for Prostate Cancer
- Co-existence of Ventricular Septal Defect and Bronchial Asthma in Two Nigerian Children
- Estimation of Hazard Functions in the Log-Linear Age-Period-Cohort Model: Application to Lung Cancer Risk Associated with Geographical Area
- Detection of RNA in the Plasma of Patients with Sporadic Creutzfeldt–Jakob Disease, Gerstmann–Straüssler Syndrome and Other Non-Transmissible Spongiform Encephalopathy Brain Disorders
- Pharmacotherapy of Chronic Heart Failure in the Elderly: A Review of the Evidence
- Management of Chronic Myeloid Leukemia with BCR/ABL Inhibitors: Current Status and Future Perspectives
- Pulmonary Tuberculosis: Focus on the Fluoroquinolones
- A Comparative Taxonomy of Parallel Algorithms for RNA Secondary Structure Prediction
- Amino Acids Enhance Adaptive Behaviour of Pseudomonas Aeruginosa in the Cystic Fibrosis Lung Environment
- Intranasal Ciclesonide in Allergic Rhinitis
- EGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups
- Zonisamide as Adjunctive Therapy for Adults with Partial-Onset Epileptic Seizures: An Efficacy and Safety Review
- Detection of Provasopressin in Invasive and Non-invasive (DCIS) Human Breast Cancer Using a Monoclonal Antibody Directed Against the C-terminus (MAG1)
- Emerging Therapies for the Management of Multiple Sclerosis
- Metabolic Abnormalities in Abstinent Methamphetamine Dependent Subjects
Most read articles
- Current Status of Monocyte Differentiation-Inducing (MDI) Factors Derived from Human Fetal Membrane Chorion Cells Undergoing Apoptosis after Influenza Virus Infection
- Relationship Between the Plasma Concentration of C-Reactive Protein and Severity of Peripheral Arterial Disease
- Intraspecific ITS Variability in the Kingdom Fungi as Expressed in the International Sequence Databases and Its Implications for Molecular Species Identification
- Clinical Presentation and Histologic Findings at Ileocolonoscopy in Children with Autistic Spectrum Disorder and Chronic Gastrointestinal Symptoms
- A Simple Derivation of the Distribution of Pairwise Local Protein Sequence Alignment Scores
- DICOM Structured Reporting and Cancer Clinical Trials Results
- Mammoth and Elephant Phylogenetic Relationships: Mammut Americanum, the Missing Outgroup
- Evaluation of Two Outlier-Detection-Based Methods for Detecting Tissue-Selective Genes from Microarray Data
- Exploring the Evolutionary History of the Differentially Expressed Genes between Human Populations: Action of Recent Positive Selection
- Systems Biology-Based Identification of Crosstalk between E2F Transcription Factors and the Fanconi Anemia Pathway
- On the Adaptive Design Rules of Biochemical Networks in Evolution
- Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges
- Fast Genes and Slow Clades: Comparative Rates of Molecular Evolution in Mammals
- Identification and Quantitation of Asparagine and Citrulline Using High-Performance Liquid Chromatography (HPLC)
- In Silico Promoter Analysis can Predict Genes of Functional Relevance in Cell Proliferation: Validation in a Colon Cancer Model
(previous 30 days)Site updates
Clinical Medicine Insights: Therapeutics
The newest antidepressant, desvenlafaxine (DVS) was approved by the FDA in early 2008 and since then, has been available in the market for general use. DVS is dual acting, a serotonin-norepinepherine reuptake inhibitor (SNRI). Like its parent compound, venlafaxine (VEN), DVS inhibits the neuronal re-uptake of both serotonin and norepinepherine...
Heart failure (HF) is a very prevalent disease in the United States and in Europe, with the highest prevalence among older patients. Population estimates suggest substantial growth among the elderly over the next four decades. However, older patients are underrepresented in clinical trials evaluating HF therapies and are less likely...
Management of Chronic Myeloid Leukemia with BCR/ABL Inhibitors: Current Status and Future Perspectives (13/Apr/2010)
Chronic myeloid leukemia (CML) is a hematopoietic neoplasm characterized by the Philadelphia chromosome (Ph) and the BCR/ABL oncoprotein. In chronic phase (CP) CML, leukemic cells display multilineage differentiation and maturation capacity. The BCR/ABL inhibitor imatinib exerts profound antileukemic effects in these patients and is considered standard frontline therapy. However, not...
Pulmonary Tuberculosis: Focus on the Fluoroquinolones (13/Apr/2010)
Fluoroquinolone antibiotics are relatively new drugs in anti-tuberculosis (TB) treatment, with the potential to become the first new class of drugs to be recommended for routine treatment since rifamycins in the 1960s. Later generation fluoroquinolones, including levofloxacin, gatifloxacin, and moxifloxacin have been found to be safe and well-tolerated in observational...
Intranasal Ciclesonide in Allergic Rhinitis (09/Apr/2010)
Allergic rhinitis affects more than 20% and is responsible for very high direct and indirect costs. Nasal corticosteroids are the principle pharmaceutical option for the treatment of allergic rhinitis. They are more effective than all other therapeutic options and in addition to improving symptoms of allergic rhinitis they also improve...
Zonisamide as Adjunctive Therapy for Adults with Partial-Onset Epileptic Seizures: An Efficacy and Safety Review (08/Apr/2010)
Purpose: To provide a review of randomized controlled trials (RCTs) on the efficacy and safety of zonisamide as an adjunctive treatment for partial-onset seizures in epilepsy patients ages 12 years and above. Methods: Medline literature search for published double-blind RCTs involving zonisamide as adjunctive treatment for simple partial, complex...
Objective: To provide a comprehensive overview on the emerging treatments used for the treatment management of multiple sclerosis (MS). Data Sources: PubMed, MEDLINE, Cochrane, and Toxnet databases were used to conduct all comprehensive literature searches over the time period of 1989 to 2009. Search terms such as: multiple sclerosis and oral...
Anticonvulsant drugs continue to be the mainstay of epilepsy treatment but benefits of seizure control need to be balanced with the psychotropic potential of this class of compounds. The present paper is aimed at discussing positive and negative effects of anticonvulsant drugs on mood in patients with epilepsy. In general...
Methadone is a synthetic opiate primarily used in the detoxification and maintenance of patients who are dependent on opiates particularly heroin. Though within last 10–15 years methadone is increasingly used to manage neuropathic and cancer pains. Unfortunately, with increased methadone use for pain is coincided with significant increase in adverse...
The evaluation and management of pulmonary arterial hypertension (PAH) is a rapidly evolving area of subspecialty medicine requiring regular clinical updates. Most notably are changes in the World Health Organization diagnostic scheme whereby the clinician categorizes the correct type of pulmonary hypertension in order direct the most specific evaluation and...
Drug Target Insights
A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy (15/Jan/2009)
NQO1 (NAD(P)H:quinoneoxidoreductase 1) is a reductive enzyme that is an important activator of bioreductive antitumor agents. NQO1 activity varies in individual tumors but is generally higher in tumor cells than in normal cells. NQO1 has been used as a target for tumor specific drug development. We investigated a series of...
The Toxicity of a Chemically Synthesized Peptide Derived from Non-Integrin Platelet Collagen Receptors (13/Aug/2008)
A chemically synthesized peptide derived from platelet non-integrin collagen receptor has been shown to be an effective agent for inhibiting collagen-induced platelet aggregation and adhesion of washed radiolabeled platelets onto natural matrices and collagen coated microtiter plates. In order to be a therapeutic agent, we have used a cell culturing...
The Target of 5-Lipoxygenase is a Novel Strategy over Human Urological Tumors than the Target of Cyclooxygenase-2 (13/Jun/2008)
The metabolism of arachidonic acid by either the cyclooxygenase (COX) or lipoxygenase (LOX) pathway generates eicosanoids, which have been implicated in the pathogenesis of a variety of human diseases, including cancer. It is now considered that they play important roles in tumor promotion, progression, and metastasis, also, the involvement of...
Study of Alkylglycerol Containing Shark Liver Oil: a Physico Chemical Support for Biological Effect? (28/May/2008)
Shark liver oil (SLO), is used in natural medicine as immunity stimulant, cardiovascular protector and anti ageing reagent. These properties were related with the high amounts of alkylglycerols (22%) obtained from Greenland shark liver. After a control of the mean SLO composition by NMR and MS, surface and membrane interactions...
Live Typhoid Vaccine for IBD-Patients—Well Tolerated and with Possible Therapeutic Effect (16/May/2008)
Background: Our incidental observation of a remarkable improvement of disease activity following vaccination against typhoid in a patient with inflammatory bowel disease (IBD) was the incentive of this pilot study. Methods: Ten IBD-patients (7 with ulcerative colitis and 3 with Crohn’s disease) with disease activity grade 2–10 on simple colitis...
Memantine: Reality and Potentiality (08/May/2008)
Memantine protects cultured neurons from excitotoxin-induced cell-death; it attenuated loss of cholinergic neurons in the CNS induced by injection of NMDA into the basal forebrain of rats. It has been shown that memantine induced production of brain-derived neurotrophic factor (BDNF), a substance shown to promote survival and differentiation of CNS...
Drug discovery and its methodologies have been very effective in terms of treating cancers and immunological disorders but have not been able to stop genetic diseases as most of the drugs target at the protein level. They merely mitigate the symptoms of the disease. Spinocerebellar ataxia is a neurological genetic...
The Beta3 499–513 Peptide Region is Required for AlphaIIb/ Beta3 Active Complex Formation and Fibrinogen Binding (28/Apr/2008)
Background: AlphaIIb/beta3 (αIIb/β3) complex is an important integrin that is involved in the final step of platelet aggregation. Peptides derived from either αIIb or β3 have demonstrated to have an effect on the activation of the complex and its ability to bind fibrinogen. We have previously defined a peptide from...
Therapies to Increase ApoA-I and HDL-Cholesterol Levels (23/Apr/2008)
Cholesterol is transported around the body in the form of lipoprotein (lipid/protein) complexes, because it is almost insoluble in water. High-density lipoprotein (HDL) particles transport cholesterol from tissues back to the liver for excretion. Epidemiological studies have shown an inverse relationship between blood levels of HDL-cholesterol (HDL-c) and the incidence...
The rapidly expanding data sets derived from genomic and transcriptomic analyses have allowed greater understanding of structural and functional network patterns within the genome resulting in a realignment of thinking within a systems biologic framework of cancer. However, insofar as spatially and temporally dynamic differential gene expression at the protein...
Perspectives in Medicinal Chemistry
This paper presents a novel unified theory of the structure activity relationship of opioids and opioid peptides. It is hypothesized that a virtual or known heterocyclic ring exists in all opioids which have activity in humans, and this ring occupies relative to the aromatic ring of the drug, approximately the...
Chaperone therapy is a newly developed molecular approach to lysosomal diseases, a group of human genetic diseases causing severe brain damage. We found two valienamine derivatives, N-octyl-4-epi-β-valienamine (NOEV) and N-octyl-β-valienamine (NOV), as promising therapeutic agents for human β-galactosidase deficiency disorders (mainly GM1-gangliosidosis) and β-glucosidase deficiency disorders (Gaucher disease), respectively. We...
Aminoglycosides: Molecular Insights on the Recognition of RNA and Aminoglycoside Mimics (28/Apr/2009)
RNA is increasingly recognized for its significant functions in biological systems and has recently become an important molecular target for therapeutics development. Aminoglycosides, a large class of clinically significant antibiotics, exert their biological functions by binding to prokaryotic ribosomal RNA (rRNA) and interfering with protein translation, resulting in bacterial cell...
Perspectives on Using Physcomitrella Patens as an Alternative Production Platform for Thapsigargin and Other Terpenoid Drug Candidates (04/Mar/2009)
To overcome the potential future demand for terpenoids used as drugs, a new production platform is currently being established in our laboratory. The moss Physcomitrella has been chosen as the candidate organism for production of drug candidates based on terpenoids derived from plants, with a primary focus on the sesquiterpene lactone, thapsigargin. This drug candidate and other candidates/drugs with sesquiterpene skeleton are difficult to obtain by chemical synthesis due to their large number of chiral...
Bioactive and Structural Metabolites of Pseudomonas and Burkholderia Species Causal Agents of Cultivated Mushrooms Diseases (09/May/2008)
Pseudomonas tolaasii, P. reactans and Burkholderia gladioli pv. agaricicola, are responsible of diseases on some species of cultivated mushrooms. The main bioactive metabolites produced by both Pseudomonas strains are the lipodepsipeptides (LDPs) tolaasin I and II and the so called White Line Inducing Principle (WLIP), respectively, LDPs which have been...
The Role of Integrins in Cancer and the Development of Anti-Integrin Therapeutic Agents for Cancer Therapy (10/Apr/2008)
Integrins have been reported to mediate cell survival, proliferation, differentiation, and migration programs. For this reason, the past few years have seen an increased interest in the implications of integrin receptors in cancer biology and tumor cell aggression. This review considers the potential role of integrins in cancer and also...
The heterogeneity of symptoms and disease progression observed in synucleinopathies, of which Parkinson’s disease (PD) is the most common representative, poses large problems for the discovery of novel therapeutics. The molecular basis for pathology is currently unclear, both in familial and in sporadic cases. While the therapeutic effects of L-DOPA...
Lunasin: A Novel Cancer Preventive Seed Peptide (25/Mar/2008)
Cancer is one of the leading causes of deaths in the Western world. Approximately one-third of these deaths are preventable by lifestyle factors, including modification of nutritional habits. Studies have demonstrated that adequate nutrition with certain types of foods containing bioactive compounds might offer significant protection against carcinogenesis. Soybeans contain...
Effects of FK506 on Ca2+ Release Channels (Review) (18/Mar/2008)
Tacrolimus (FK506), which was isolated from the fermentation broth of Streptomyces tsukubaensis No. 9993, has an immunosuppressive effect. In T-lymphocytes, FK506 binds to the intracellular receptor, a 12-kDa FK506-binding protein (FKBP12). The FK506-FKBP12 complex binds to the phosphatase calcineurin (CN) and inhibits the activity of CN. By inhibition of the...
Small Family with Key Contacts: Par14 and Par17 Parvulin Proteins, Relatives of Pin1, Now Emerge in Biomedical Research (07/Mar/2008)
The parvulin-type peptidyl-prolyl cis/trans isomerase Pin1 is subject of intense biochemical and clinical research as it seems to be involved in the pathogenesis of certain cancers and protein folding illnesses like Alzheimer’s and Parkinson’s disease. In addition to Pin1, the human genome only contains a single other parvulin locus encoding...
Translational Oncogenomics
Anticipation in Families with Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders (30/Mar/2010)
Fifty-one parent-offspring pairs with chronic lymphocytic leukemia (CLL) or other lymphoproliferative disorders (nonCLL) such as malignant lymphoma, multiple myeloma, or other types of lymphocytic leukemia than CLL were ascertained independently in 38 families. There were 30 CLL-CLL parent-offspring pairs and 21 pairs with nonCLL in parents and/or in offspring. The...
The myelodysplastic syndromes (MDS) are clonal stem cell disorders, characterized by ineffective and dysplastic hematopoiesis. The genetic and epigenetic pathways that determine disease stage and progression are largely unknown. In the current study we used gene expression microarray methodology to examine the gene expression differences between normal hematopoietic cells and...
Protein Multifunctionality: Principles and Mechanisms (15/May/2008)
In the review, the nature of protein multifunctionality is analyzed. In the first part of the review the principles of structural/functional organization of protein are discussed. In the second part, the main mechanisms involved in development of multiple functions on a single gene product(s) are analyzed. The last part represents...
Sirtuins are NAD+-dependent histone deacetylases (Class III HDACs). Recently, Sirtuins have been shown to play important roles, both direct and indirect, in transcriptional regulation. This transcriptional control, through incorporation of Sirtuins into transcription complexes and deacetylation of histones locally at gene promoters, or direct interaction with specific transcription factors, is...
Implication of Ceramide, Ceramide 1-Phosphate and Sphingosine 1-Phosphate in Tumorigenesis (10/Apr/2008)
In the last two decades there has been considerable progress in our understanding of the role of sphingolipids in controlling signal transduction processes, particularly in the mechanisms leading to regulation of cell growth and death. Ceramide is a well-characterized sphingolipid metabolite and second messenger that can be produced by cancer...
Gene associated with retinoid-interferon-β-induced mortality (GRIM)—19, was originally identifi ed as a critical regulatory protein necessary for Interferon-β-Retinoic acid-induced cell death. Overexpression of GRIM-19 activates cell death and its suppression or inactivation promotes cell growth. GRIM-19 targets multiple proteins/pathways for exerting growth control and cell death. However, GRIM-19 is also...
Obesity, Adipocytokines and Cancer (17/Mar/2008)
A great amount of literature has demonstrated a connection between obesity, visceral fat and the metabolic disorders such as hyperglycemia, hypertension, and hyperlipidemia. Lately, there has been an increased interest in understanding if cancer is related to obesity and visceral fat accumulation. The prevalence of both obesity and cancer are...
Sudeep K. Bose, Rebecca S. Bullard and Carlton D. Donald Department of Pathology and Laboratory Medicine, Medical University of South Carolina (MUSC), 165 Ashley Avenue, PO Box 250620, Charleston, SC—29425, U.S.A. Abstract Prostate cancer is the second leading cause of cancer death among men in the United States...
Possible Imprinting and Microchimerism in Chronic Lymphocytic Leukemia and Related Lymphoproliferative Disorders (10/Feb/2008)
Viggo Jønsson1, Geir E. Tjønnfjord2, Tom B. Johannesen3, Sven Ove Samuelsen4 and Bernt Ly5 1Department of Hematology, Aker University Hospital, University of Oslo, Norway. 2Department of Hematology, Rikshospital and Radium Hospital, University of Oslo, Norway. 3,5The National Norwegian Cancer Registry, Oslo, Norway. 4Department of Biostatistics, Faculty of Mathematics, University...
Sheng Wang and Douglas V. Faller Boston University School of Medicine, Cancer Research Center, Boston, MA, U.S.A. Abstract Tumor formation results from alterations in the normal control of cell proliferation. In the past decade, much attention in cancer research has been focused on the function of proto-oncogenes...